Financhill
Back

Bright Minds Biosciences Quote, Financials, Valuation and Earnings

Bright Minds Biosciences Price Quote

$24.59
-12.91 (-34.43%)
(Updated: October 16, 2024 at 10:20 AM ET)

Bright Minds Biosciences Key Stats

Sell
50
Bright Minds Biosciences (DRUG) is a Sell

Day range:
$2.47 - $37.99
52-week range:
$0.93 - $37.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
37.59%

Volume:
99.3M
Avg. volume:
3.8M
1-year change:
2303.85%
Market cap:
$167.4M
Revenue:
$0
EPS:
$-0.68

How Much Does Bright Minds Biosciences Make?

Data Unavailable

Is Bright Minds Biosciences Growing As A Company?

Data Unavailable

Bright Minds Biosciences Stock Price Performance

What Is Bright Minds Biosciences 52-Week High & Low?

Bright Minds Biosciences Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bright Minds Biosciences?

Is Bright Minds Biosciences Cash Flow Positive?

  • What Is DRUG Cash Flow From Operations?
    Cash flow from operations (TTM) is -$1.9M
  • What Is Bright Minds Biosciences’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $588K
  • What Is Bright Minds Biosciences’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Bright Minds Biosciences Return On Invested Capital

Data Unavailable

Bright Minds Biosciences Earnings Date & Stock Price

Bright Minds Biosciences Competitors

Bright Minds Biosciences Dividend Yield

Bright Minds Biosciences Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many DRUG shares are owned by institutional investors?
    192.5K DRUG shares are owned by institutional investors
  • How many DRUG shares are owned by insiders?
    0 DRUG shares are owned by insiders